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Material and Methods: A rat model was used to investigate a 
possible selective accumulation of circulating lymphocites to 
specific anatomical districts after radiation treatment 
focused to the urinary bladder. Eight Fisher rats were 
adoptively transferred with 4x107 VivoTag-750-labelled 
syngeneic primary splenocytes at two hours before the 
bladder irradiation. Two of eight rats were used as controls. 
Animals were transurethrally catheterized to allow contrast 
agent instillation. A kV cone beam computed tomography 
(CBCT) was acquired for each rat, to precisely deliver 6 MeV 
monofraction photon field. Rats were divided into three 
groups (n=2/group) receiving different levels of dose: 15, 20 
and 25 Gy. A bolus thickness equal to 1cm was positioned on 
the rat skin surface in the pelvic region. Ultrasound images of 
the pelvic region were acquired at baseline, at 2, 4 and 6 
days after irradiation to monitor thickness variations of the 
bladder wall tissue. In vivo fluorescent imaging was used to 
evaluated accumulation sites of labelled leukocytes. 
 
Results: A significant increase in the bladder wall thickness 
was found 4 days after irradiation in animals treated with a 
dose equal to 25 Gy. A fluorescent signal, secondary to 
labelled splenocytes accumulation, emerged in the liver and 
lymph nodes of all adoptively transferred rats, 2 and 6 days 
after irradiation, as expected. A modest specific signal (30% 
increase) at the bladder level resulted only in two animals 
receiving the higher dose (Figure 1.a), when compared to the 
non-irradiated (Figure 1.b). No specific fluorescent signal was 
detected at the bladder levels in animals treated with 20 and 
15 Gy. 
 
 
 
Conclusion: The relocalization of peripheral leukocytes in 
the damaged tissue depends on the radiation dosage and it 
may be evaluated by means of a non-invasive imaging 
technique. Further analyses are currently ongoing. 
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Purpose or Objective: Lung cancer is one of the most 
frequent and deadly types of cancer in Europe. Several 
aspects of non-small cell lung cancer (nsclc) in men and 
women continue to indicate potential male-female 
differences. Among these, higher treatment responses to 
current therapies in women are supposed, since women have 
better prognosis in any stage of the disease. In most stages of 
nsclc cytotoxic anti-cancer therapy (radiotherapy, 
chemotherapy) is used. It is known that treatment efficacy of 
cytotoxic anti-cancer therapy depends on tumor DNA-repair. 
Therefore, the aim of this study was to evaluate gender 
differences in the expression of DNA repair enzyme DNA 
protein kinase (DNA-PK). 
Material and Methods: Surgically excised nsclc tissues 
(n=111, 50 adenocarcinomas, 61 squamous cell carcinomas) 
were examined for DNA-PK expression. After 
immunohistochemistry, the staining intensity of DNA-PK was 
quantified using an arbitrary score ranging from 0 (no 
staining) to 3 (strong signal). Also, the proportion (%) of DNA-
PK positive (DNA-PK+) tumor cells was determined. All 
parameters were examined by 2 independent researchers in 
10 randomly chosen microscopic fields (magnification x40). 
 
Results: Immunohistochemical parameters were examined by 
2 independent researchers whose results were in good 
accordance (p<0.0005). Staining intensities of DNA-PK and 
the proportion of DNA-PK+ tumor cells varied, being in the 
whole nsclc group 2.4±0.4 (mean±SD) and 86.3±9.1% 
respectively. There were no significant gender differences in 
adenocarcinoma. However, we detected significant 
differences among nsclc patients with squamous cell 
carcinoma. Both, DNA-PK staining intensity and the 
proportion of DNA-PK+ tumor cells were significantly higher 
in men than in women, 2.5±0.3 and 86.3±8.8% vs 2.1±0.6 and 
79.6±11.9% respectively (DNA-PK intensity: p<0.01; DNA-PK+ 
proportion: p=0,03). Additionally, we found that in squamous 
cell carcinoma, the expression of DNA-PK depends on smoking 
and pack-years. There was a correlation between pack-years 
and DNA-PK intensity (p=0.04), as well as between pack-years 
and the proportion of DNA-PK+ tumor cells (p=0.04). 
 
Conclusion: Expression of DNA-PK in squamous cell lung 
cancer has gender differences and depends on smoking. 
Significantly lower expression of tumor DNA-PK was found in 
women with this histological subtype of nsclc. Latter might 
be one of the reasons why cytotoxic anti-cancer therapy is 
more efficacious in women than in men. In further studies, 
the combination of DNA repair inhibitors and cytotoxic anti-
cancer therapy should be tested. 
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Purpose or Objective: Selecting good responders after 
chemoradiation (CRT) for locally advanced rectal cancer 
(LARC) could lead to the omission of total mesorectal 
excision (TME) in patients with pathologic complete response 
(pCR). In the current study, we assessed the value of several 
blood biomarkers associated with the fibrotic response to 
CRT (IGF-1, IGFBP-2, HGF & GDF-15) as markers for general 
fibro-inflammatory response and as tumor response 
predictors in a group of 80 patients. 
 
Material and Methods: ELISA analysis of IGF-1, IGFBP-2, HGF 
and GDF-15 was conducted on prospectively collected serum 
samples of 80 LARC patients on 3 time points (before, during, 
after CRT). The fibro-inflammatory response was scored on 
H&E sections of the resection specimen. Changes in 
concentration were analysed using a Kruskal-Wallis test. 
Correlation of concentration at each time point and the 
difference between these time points (Δ) with fibro-
inflammatory response and tumor response (pCR and ypT0-1) 
were assessed using a Mann-Whitney-U test. 
 
Results: Higher Growth Differentiation Factor 15 (GDF-15) 
concentration before CRT correlated with the presence of a 
fibro-inflammatory response (p = 0.04), but was not observed 
for the other proteins nor for GDF-15 at other time points.  
General increase in GDF-15 concentration during treatment 
(median 0.81 ng/ml before, 2.16 ng/ml during, 2.37 ng/ml 
after CRT; p <0.0001) was measured (Figure 1). Although no 
significant general concentration changes occurred for IGF-1, 
IGFBP-2 or HGF, we did find a correlation between the 
variation in expression of IGFBP-2 during treatment (ΔIGFBP-2 
TP3-TP2) with tumor response (pCR p = 0.02; ypT0-1 p = 
0.02). Other proteins did not correlate with tumor response. 
 
 
 
Conclusion: GDF-15 serum concentration increases during 
CRT for LARC and a higher concentration measured before 
start of treatment is correlated with the presence of a fibro-
inflammatory response. These results suggest that GDF-15 
could be used as an early predictor of fibro-inflammatory 
response and thereby indirectly as predictor for disease-free 
survival. This will be evaluated when follow-up data are 
available for this patient cohort.  
The correlation of variation in expression of IGFBP-2 with 
tumor response (pCR and ypT0-1) opens a novel possibility for 
selecting good responders to CRT. We aim to combine these 
findings with imaging analyses (DW-MRI, PET) at different 
time points during treatment to develop a predictive model 
for selecting LARC patients in whom surgery could be 
omitted. 
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Purpose or Objective: Hypoxia is a common feature in 
prostate cancer and is known to reduce the response to 
radiotherapy. Hypoxic modifiers can to a large extent 
overcome these obstacles, and a proper classification of 
tumors into hypoxic and non-hypoxic fractions is necessary. 
Previously our department has developed a gene profile 
consisting of 15 genes, which demonstrated prognostic and 
predictive impact for hypoxic modification in head and neck 
squamous cell carcinomas (HNSCC). In the current study we 
investigated the 15 gene profile in different prostate cancer 
cell lines. 
 
Material and Methods: For the in vitro experiments the 
prostate cancer cell lines investigated were PC-3, DU-145, 
and LNCaP. Cell lines were cultured under normoxic (21% O2) 
or hypoxic conditions (0% O2) for 24 hours, totRNA was 
extracted and gene expression levels measured by qPCR. 
Individual reference genes were selected (PSMC4, TBP, 
NDFIP1) and applied in the normalization of the relative 
expression levels, together with the reference genes 
previously used in the HNSCC study. For in vivo experiments, 
the PC3 cell line was inoculated on the flank of female NMRI 
nu/nu mice, whereas the LNCaP and DU-145 cell lines were 
inoculated on the flank of severely immunocompromised 
CIEA/NOG mice. Two hypoxia-sensitive tracers (18F-FAZA and 
Pimonidazole) were administered in order to determine 
hypoxic and non-hypoxic regions on excised tumor sections. 
These regions were isolated by laser-assisted microdissection, 
after which totRNA was extracted and gene expression levels 
measured by qPCR. 
 
Results: In the in vitro experiments, all prostate cancer cell 
lines had 14 of the 15 genes induced by hypoxia. The only 
discrepancy was ALDOA, which was not upregulated in the 
hypoxic cells. In vivo experiments are still ongoing but 
preliminary results from PC3 xenografts have been produced. 
These show a hypoxia induced upregulation in 10 out of the 
15 genes, of which 4 were significantly upregulated (ADM, 
ANKRD37, FAM162A, and LOX). 
 
Conclusion: In this study we investigated the 15 gene hypoxic 
profile in three different prostate cancer cell lines. A hypoxia 
dependent induction of genes was observed in both in vitro 
and in vivo experiments. From the performed experiments, 
and looking only at oxygen dependency, it appears that the 
gene profile could be suitable for prostate cancers as well as 
HNSCC. 
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Purpose or Objective: Acute radiotoxicity might put a vital 
threat to the patient and may require interruption or 
